MHApp - Malignant Hyperthermia 12+
Girard Development GmbH
Zaprojektowano dla iPada
-
- Gratis
Zrzuty ekranu
Opis
Finally it’s back! The much appreciated MHApp is finally back in the AppStore. Rewritten from ground up in Swift. A modern user interface.
And the best is: it is free of charge!
Please note: MHApp is not a substitute for medical advice. MHApp is intended for educational purposes only. The purpose of this app is to use it to train and teach yourself in management of malignant hyperthermia. It might serve as a valuable tool in simulated MH scenarios.
Do you know what to do in case of a malignant hyperthermia crisis?
Are you sure somebody will take a detailed protocol during your actions?
MHApp does both for you:
MHApp is like an interactive MH-emercency poster. Simulating an MH crisis and teaching the acute management will certainly be of great value in case of a real crisis.
MHApp will guide you through a simulated malignant hyperthermia (MH) crisis. The App includes treatment of acidosis, hyperkalemia and dosing of dantrolene or ryanodex
Every action and injected dantrolene doses are recorded in a log file, which can be exported.
The clinical grading score (CGS) estimates the probability of an MH episode. The result can be exported as PDF.
A section with information about MH, anesthesia for the known MH patients, preparation of anesthesia workstations, MH-mutations and more.
This app was developed by international experts in Malignant Hyperthermia:
Dr. Henry Rosenberg (President of MHAUS)
Prof. Thierry Girard (director of the Swiss MH unit)
MHApp is endorsed by the North American MH Group (www.mhaus.org), as well as by the European MH Group (www.emhg.org).
Programmed by
Thierry Girard, Girard Development GmbH
DISCLAIMER:
The application MHApp is not a substitute for medical advice. MHApp is intended for educational purposes only. While the data may be updated periodically, users should independently check medical literature and package inserts or other sources for the latest information.
Any and all liability arising directly or indirectly from the use of this application is hereby disclaimed. The information herein is provided "as is" and without any warranty expressed or implied. All direct, indirect, special, incidental, consequential or punitive damages arising from any use of this application or data contained herein is disclaimed and excluded.
Co nowego
Wersja 2.4
minor improvements
Prywatność w aplikacji
Deweloper (Girard Development GmbH) wskazał, że zasady ochrony prywatności w aplikacji mogą obejmować opisane poniżej metody przetwarzania danych. Aby dowiedzieć się więcej, zapoznaj się z zasadami ochrony prywatności dewelopera.
Dane nie są gromadzone
Deweloper nie gromadzi żadnych danych z tej aplikacji.
Zasady ochrony prywatności mogą się różnić, np. w zależności od używanych funkcji lub Twojego wieku. Więcej informacji
Informacje
- Dostawca
- Girard Development GmbH
- Wielkość
- 4,6 MB
- Kategoria
- Medycyna
- Zgodność
-
- iPhone
- Wymaga systemu iOS w wersji 13.0 lub nowszej.
- iPad
- Wymaga systemu iPadOS w wersji 13.0 lub nowszej.
- iPod touch
- Wymaga systemu iOS w wersji 13.0 lub nowszej.
- Mac
- Wymaga systemu macOS w wersji 11.0 lub nowszej oraz Maca z czipem Apple M1 lub nowszym.
- Apple Vision
- Wymaga systemu visionOS w wersji 1.0 lub nowszej.
- Języki
-
Angielski, Niemiecki
- Wiek
- 12+ Rzadkie/łagodne informacje o medycynie/leczeniu
- Prawa autorskie
- © 2022 Girard Development
- Cena
- Gratis